Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Masato Tsuyuguchi"'
Autor:
Asaka Ikeda, Masato Tsuyuguchi, Daisuke Kitagawa, Masaaki Sawa, Shinya Nakamura, Isao Nakanishi, Takayoshi Kinoshita
Publikováno v:
Biochemical and biophysical research communications. 630
Casein kinase 2 (CK2) is a vital protein kinase that consists of two catalytic subunits (CK2α1 and/or CK2α2) and two regulatory subunits (CK2β). CK2α1 is a drug target for nephritis and cancers, while CK2α2 is a serious off-target because its in
Publikováno v:
Acta Crystallogr F Struct Biol Commun
Protein kinase CK2a1 is a serine/threonine kinase that plays a crucial role in the growth, proliferation and survival of cells and is a well known target for tumour and glomerulonephritis therapies. Here, the crystal structure of the kinase domain of
Autor:
Ryuichi Kato, Tomohiro Tanaka, Hiroshi Manya, Tamao Endo, Rieko Imae, Mamoru Mizuno, Naoyuki Kuwabara, Masato Tsuyuguchi
Publikováno v:
Genes to cells 26(7), 485-494 (2021). doi:10.1111/gtc.12853
Genes to Cells
Genes to Cells
Genes to cells 26(7), 485-494 (2021). doi:10.1111/gtc.12853
Defects in the O-mannosyl glycan of ��-dystroglycan (��-DG) are associated with ��-dystroglycanopathy, a group of congenital muscular dystrophies. While ��-DG has many O
Defects in the O-mannosyl glycan of ��-dystroglycan (��-DG) are associated with ��-dystroglycanopathy, a group of congenital muscular dystrophies. While ��-DG has many O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4832aa99c08d917a9512815470fca41
https://bib-pubdb1.desy.de/record/472498
https://bib-pubdb1.desy.de/record/472498
Publikováno v:
Acta Crystallogr F Struct Biol Commun
The catalytic subunits of protein kinase CK2 are classified into two subtypes: CK2α1 and CK2α2. CK2α1 is an attractive drug-discovery target for various diseases such as cancers and nephritis. CK2α2 is defined as an off-target of CK2α1 and is a
Publikováno v:
Bioorganicmedicinal chemistry letters. 30(2)
Casein kinase 2 catalytic subunit (CK2α) is classified into two subtypes CK2α1 and CK2α2. CK2α1 is a drug discovery target, whereas CK2α2 is an off-target of CK2α1 inhibitors. High amino acid sequence homology between these subtypes hampers eff